The median follow-up was 27.5 months. As of the data cutoff (August 25, 2025), 14% of patients in the Dato-DXd arm and 3% of those in the chemotherapy arm remained on treatment. The median treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback